Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Staff experiences of percutaneous tracheostomy in intensive care: challenges, complications and potential solutions.

Anaesthesia reports·2026
Same author

Pre- and post-cranioplasty hydrocephalus in patients following decompressive craniectomy for ischemic stroke: a systematic review and meta-analysis.

Neurosurgical review·2025
Same author

The Impact of Inoculation of Two Strains of Rhizobacteria on Radionuclide Transfer in Sesbania Grandiflora.

Bulletin of environmental contamination and toxicology·2024
Same author

Prevention and screening during the COVID-19 pandemic: qualitative findings from the BETTER WISE project.

BMC primary care·2023
Same author

D-Dimer May be a Prognostic Hematological Marker for COVID-19: A Retrospective Case Analysis.

Mymensingh medical journal : MMJ·2021
Same author

Sub-continental Atmosphere and Inherent Immune System may have Impact on Novel Corona Virus' 2019 (nCovid-19) Prevalence in South East Asia.

Mymensingh medical journal : MMJ·2020

Related Experiment Video

Updated: Jun 28, 2026

miRNA Expression Analyses in Prostate Cancer Clinical Tissues
11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

MicroRNA profile analysis of human prostate cancers.

A W Tong1, P Fulgham, C Jay

  • 1Gradalis, Inc., Dallas, TX, USA. alext@baylorhealth.edu

Cancer Gene Therapy
|October 25, 2008
PubMed
Summary

This study reveals that altered microRNA (miRNA) expression is linked to prostate cancer development and early relapse. Restoring specific miRNAs inhibited cancer cell growth, suggesting potential therapeutic applications.

More Related Videos

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR (qPCR)
08:30

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR (qPCR)

Published on: May 16, 2012

Laser-capture Microdissection of Human Prostatic Epithelium for RNA Analysis
07:42

Laser-capture Microdissection of Human Prostatic Epithelium for RNA Analysis

Published on: November 26, 2015

Related Experiment Videos

Last Updated: Jun 28, 2026

miRNA Expression Analyses in Prostate Cancer Clinical Tissues
11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR (qPCR)
08:30

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR (qPCR)

Published on: May 16, 2012

Laser-capture Microdissection of Human Prostatic Epithelium for RNA Analysis
07:42

Laser-capture Microdissection of Human Prostatic Epithelium for RNA Analysis

Published on: November 26, 2015

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Prostate cancer progression involves complex molecular changes.
  • MicroRNAs (miRNAs) are key regulators of gene expression implicated in oncogenesis.
  • Understanding miRNA dysregulation in prostate cancer is crucial for identifying biomarkers and therapeutic targets.

Purpose of the Study:

  • To investigate the microRNA (miRNA) expression profile in prostate cancer tissues.
  • To correlate miRNA expression patterns with tumor stage, relapse, and oncogenesis.
  • To explore the functional role of specific miRNAs in prostate cancer cell growth.

Main Methods:

  • Analysis of miRNA expression in 40 prostatectomy specimens using high-throughput liquid-phase hybridization (mirMASA) with 114 miRNA probes.
  • Paired analysis of malignant and non-involved tissue areas.
  • Validation of miRNA expression using quantitative reverse transcription (qRT)-PCR.
  • Functional assays involving ectopic miRNA expression in LNCaP cancer cells.

Main Results:

  • Five miRNAs (miR-23b, -100, -145, -221, -222) were significantly downregulated in malignant prostate tissues.
  • Lowered expression of miR-23b, -145, -221, and -222 was validated by qRT-PCR.
  • Ectopic expression of these miRNAs inhibited LNCaP cancer cell growth.
  • A distinct miRNA expression profile was observed in patients with early relapse compared to non-relapse patients.
  • Increased expression of miR-135b and miR-194 showed a trend in early relapse patients.

Conclusions:

  • Altered miRNA expression signatures are associated with prostate oncogenesis.
  • Specific miRNA expression patterns may predict early disease relapse.
  • Reconstitution of miRNA expression holds potential for experimental prostate cancer therapy.